Leerink Partnrs Has Bearish Forecast for Immunic Q1 Earnings
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Equities researchers at Leerink Partnrs dropped their Q1 2025 earnings estimates for Immunic in a research note issued on Tuesday, April 1st. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings per share of ($0.25) for the quarter, down from their prior forecast of […]
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Equities researchers at Leerink Partnrs dropped their Q1 2025 earnings estimates for Immunic in a research note issued on Tuesday, April 1st. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings per share of ($0.25) for the quarter, down from their prior forecast of […]
